Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy
The TyG index is a long-term predictor of the efficacy of immunotherapy combined with chemotherapy, and patients with a high index have a better prognosis.
Authors
- Zhiyuan Yao (ORCID: https://orcid.org/0000-0001-9671-4208)
- Jun Song (ORCID: https://orcid.org/0000-0002-1949-8844)
- Zhengxiang Han (ORCID: https://orcid.org/0000-0003-2463-8933)
- Yu Cui (ORCID: https://orcid.org/0000-0002-3480-0730)
- Jie Liu (ORCID: https://orcid.org/0009-0009-7541-9205)
- Xiao Ma
Institutions
- Xuzhou Medical College (CN)
- Affiliated Hospital of Xuzhou Medical College (CN)
- Second Affiliated Hospital of Nanjing Medical University (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2024-12-30
- DOI
- https://doi.org/10.3748/wjg.v31.i5.102249
- Citations
- 10
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.19
Funders
- Xuzhou Medical University